Status:
UNKNOWN
Evaluation of Metabolic Activity of Liver Metastases by FDG-PET Scanning
Lead Sponsor:
Radboud University Medical Center
Conditions:
Colorectal Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of primary tumor resection on the metabolic activity of metastases in patients with a colorectal primary tumor and synchronous liver metastases by p...
Detailed Description
The goal of this study is to evaluate the activity of liver metastases before and after resection of the primary tumor. Non-invasive assessment of tumor metabolism is possible in vivo by means of posi...
Eligibility Criteria
Inclusion
- Colorectal cancer and synchronous liver metastases
Exclusion
- Pregnancy
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00184782
Start Date
September 1 2003
End Date
December 1 2008
Last Update
September 21 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Nijmegen Medical Centre
Nijmegen, Gelderland, Netherlands, 6500 HB